- $1.68bn
- $1.43bn
- $655.35m
Brief: Biopharma Credit To Invest Up To $200 Million In Novocure Unit
Brief: Novocure Q1 Revenue USD 138.503 Million Vs. IBES Estimate USD 131.4 Million
Novocure Ltd expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Netflix, Reddit, Stoke Therapeutics
U.S. STOCKS ON THE MOVE-Spirit Airlines, Cintas, Reddit
U.S. STOCKS ON THE MOVE-GameStop, General Electric, Merck
Novocure surges as cancer therapy succeeds in late-stage trial
Novocure's lung cancer therapy succeeds in late-stage trial (updated)
Novocure's lung cancer therapy succeeds in late-stage trial
Novocure Ltd reports results for the quarter ended in December - Earnings Summary
Brief: Novocure Q4 Revenue USD 133.784 Million Vs. IBES Estimate USD 131.2 Million
Novocure Ltd expected to post a loss of 52 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-ONEOK, US hospital operators, BridgeBio
Novocure rises after FDA accepts premarket application for cancer treatment
U.S. STOCKS ON THE MOVE-Apple, Humana, Birkenstock
Novocure rises after FDA accepts premarket application for cancer treatment
Brief: Novocure Announces FDA Acceptance Of The Pma Application For Ttfields Therapy In Non-Small Cell Lung Cancer
Brief: Novocure Announces Last Patient Enrolled In Phase 3 Trident Trial In Newly Diagnosed Glioblastoma
Brief: Novocure Preliminary Full Year 2023 Net Revenues Of $509 Mln And Q4 Net Revenues Of $134 Mln